Dr. Christopher Wasden

Dr. Chris Wasden is Director of the Sorenson Center for Discovery and Innovation at the University of Utah. Previously he was a Managing Director at PwC and the Global Healthcare Innovation Leader. As a global thought leader on Digital Health and the role that Social, Mobile, Analytic and Cloud technologies are transforming healthcare he has written and published over 40 articles and reports on the topic, and he speaks at over 30 events each year on how Digital Health is transforming the practice of medicine, the delivery of care, and the creation of an entirely new wellness paradigm based upon objective measures that lead to greater engagement and changes in human behavior. He advises leading companies on how mobile sensors and Digital Health innovations can create new markets and opportunities (AT&T, Telefonica, Vodafone, Swisscom, Sharp, HCSC, Nokia, RIM, Roche Diagnostics, Eisai Pharmaceuticals, Genentech, Partners Healthcare, just to name a few).  He is a named inventor on 11 issued patents and has been a leader in 10 different startups where he developed many of his ideas around the innovation cycle and lifecycle and how fast, frequent, frugal, and failure accelerates innovation. Dr. Wasden has a doctorate in human and organizational learning from George Washington University in Washington, DC, an MBA from the UCLA Anderson School, and bachelor degrees in accounting (BS) and Asian studies (BA) from Brigham Young University in Provo, Utah.

Editors’ Note: This blog is part 2 of a series on Digital Health, which aims at presenting the challenges of the new digital revolution and demonstrating how digital health is empowering people to better track, manage, and improve their own health. For part 1 of this series click here . During the European MedTech Forum (2-4 December 2015) follow the conversation and learn from industry experts using the Twitter hashtag #mtf2015 The biggest failure in healthcare is that no one has ever considered the consumer (aka the patient) the customer. Consequently, all stakeholders such as governments, private payers, medtech and pharma companies, and providers almost always ignore consumer-oriented value propositions, and instead focus on creating and delivering their value propositions to one another. This has resulted in healthcare systems around the world failing to deliver on the triple aim of affordable, accessible, and effective healthcare, with the most pronounced failures occurring in the United States. Four digital technologies I call SMAC (Social, Mobile, Analytic and Cloud) are now putting the consumer at the center of healthcare and beginning to radically disrupt healthcare as they already have retail, travel, and media. This disruption is now creating powerful tensions that are now creating the “end of healthcare and medtech as we know it” and ushering in the Digital Health Revolution. So what’s the problem? Medtech firms have not yet figured out how to harness 10 tensions created by these new Digital Health technologies to validate, package and promote their solutions as effectively as drug companies do to drive mass adoption. 1) Money Tension – clinicians and health systems will only adopt Digital Health if they can make more money; yet the primary value of Digital Health is to improve the triple aim: better outcomes, greater access, affordable care (lower costs). Digital Health...